HR+/HER2- High-risk Breast Cancer Therapy
Improving Outcomes in Patients With High-risk Breast Cancer: Outcomes and Analysis From an Educational Program on HR+/HER2- Early and Metastatic Breast Cancer

Released: December 11, 2024

Expiration: December 10, 2025

Activity

Progress
1
Course Completed